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Introduction
COVID-19, a recently established global pandemic, is linked to infection by the SARSCoV-2 virus. This virus shares many structural similarities to the SARS-CoV virus that was
responsible for the 2003-2004 SARS outbreak1.SARS-CoV-2 (thought to be a -coronavirus of
B lineage2) is responsible for causing COVID-19 and shares many similarities to other viruses
in the coronavirus family. Coronavirus comprise the Coronavirinae subfamily, which exists
within the Coronaviridae family of the Nidovirales order3. Coronavirinae make up the largest
of viruses, being approximately 30 kilobases long, and contain positive-sense RNA strands
enveloped in a nucleocapsid (unusual for positive-sense RNA)4. The spike protein (S)
participates in the binding of the angiotensin-converting enzyme 2 (ACE2) and subsequent
fusion of the viral and host cellular membrane. It is comprised of 22 of the 23 N-glycosylation
sites that are found in SARS-CoV, and 76% of the protein’s genomic sequence is shared
between the two viruses2,5. This review discusses the mechanism of action between the S
protein and the host cell receptor.
1. Overview of Spike Protein Function
The general process of SARS-CoV-2 entry into host cells is well known. It is the result
of a multi-step process that involves structural changes and processing of the spike protein6.
The spike protein (S) is a homo-trimer7, with each monomer composed of S1 and S2 subunits.
Following S cleavage by the host proteases, such as furin or trypsin, S1 and S2 are connected
via non-covalent bonds. This bound, prefusion conformation of the subunits exhibit the ideal
arrangement for subsequent cleavage of the S2 subunit that allows for the fusion of viral
membrane with that of the host cell.
The S2 subunit is further cleaved by host proteases at a site known as S 2’ to facilitate
fusion with the host cell8. Hoffmann et al. demonstrate the importance of the serine protease
TMPRSS2 in preparing the S protein for fusion5. This allows for a hydrophobic internal fusion
peptide to be inserted into the transmembrane, forming an intermediate pre-hairpin
structure with the host cell9. The presence of this fusion peptide, along with two heptadrepeat regions (HR1 and HR2), have led researchers to classify the S glycoprotein as a class I
fusion protein. Key differences between the S protein and other class I fusion proteins,
however, may warrant a reevaluation of this categorization 10. Incidentally, the similarities in
HR1 and HR2 sequence alignment between that of HIV and SARS-CoV9 (and SARS-CoV-2, by
extension) may also provide clearer insight into the high infection rate seen with COVID-19.
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S1 SUBUNIT
PRIMARY FUNCTION
Receptor binding
LOCATION IN SPIKE GENE N-terminus to linker region
SEQUENCE
CLEAVAGE SITE
S1/S2 (between CTD and
linker region)
CONTAINS
N-terminal domain (NTD)
and C-terminal domain
(CTD)

S2 SUBUNIT
Membrane fusion
Linker region to C-terminus
S2’ (between linker region
and fusion peptide)
Fusion peptide, heptad
repeats 1 and 2 (HR1, HR2),
transmembrane
domain
(TM) and ectodomain (E)

Table 1. Comparison of the S1 and S2 subunits of the SARS-CoV-2 spike protein

2. Amino Acid Residue Interactions
In humans, the spike protein of SARS-CoV-2 is observed to bind with high affinity to
ACE2. In a 2020 study on recognition between the two, Yan et al. 8 attempt to rationalize the
strong binding pattern through a study of the peptidase domain (PD) of ACE2 bound to the
RBD of the S protein. Their research suggests that changes in the positioning of nonpolar
residues in SARS-CoV-2 may account for the formation of salt bridges and van der Waals
interactions, leading to stronger associations between the RBD and peptidase domain (PD) in
ACE2 in some areas, and weaker interactions in others.
Chen et al. propose that a difference in a single amino acid residue (F486) in the RBD
sequence of SARS-CoV and SARS-CoV-2 corresponds to increased binding to ACE2 because
phenylalanine, having a large, nonpolar R-group, is able to better insert into the ACE2 binding
pocket2. Other research, on the other hand, presents evidence of drastically enhanced
binding between the RBD in SARS-CoV-2 and ACE2 due to a mutation from Arg to Thr at the
501 position1. Additionally, other variations in the RBD between the two -coronaviruses may
have a direct impact on binding affinity8.
3. Receptor Recognition by Spike Proteins
Host cell recognition by SARS-CoV-2 is the first step in COVID-19 infection7. Receptor
binding in SARS-CoV has been shown to be triggered indirectly by low pH in the surrounding
environment, which induces the lysosomal release of proteases that cleave the S1 and S2
subunits6. There is a strong possibility that these findings may be similar to the triggering of
SARS-CoV-2 binding. The specific role that ACE2 plays in viral infection remains unclear. There
is recent evidence to support that ACE2 is cleaved near the C-terminus by host proteases as
well, further facilitating SARS-CoV-2 entry into exposed cells8. There is debate, however, on
whether cleavage at S2’ is essential for membrane fusion10,11. Inhibition of this process could
prove a potent target for COVID-19 treatments.
Much of the recent research on human CoV-2 infections have focused on establishing the
similarities and differences between the S protein mechanism of action in SARS-CoV and
SARS-CoV-2. The interaction between the receptor binding domain (RBD) of the virus and host
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receptor is a key step in the infection of an organism. The RBD is found in the S 1 subunit, on
the outermost point of the S protein3. Peptidases, such as ACE2, are typically used as
receptors, although binding has been observed in instances absent these enzymes. Previous
studies have presented observations of binding between S1 in -coronaviruses and sugarmediated receptors12. As an attempt to understand SARS-CoV-2 binding in the absence of
ACE2, Ibrahim et al.7 studied how the spike protein on the novel coronavirus binds to glucose
regulating protein 78 (GRP78). Molecular docking revealed hydrogen bonding and van der
Waals interactions between S1 and GRP78, resulting in efficient binding to a non-protease
receptor. Successful binding between SARS-CoV-2 and a sugar receptor may be linked to nonrespiratory-related symptoms attributed to COVID-19.
4. Fusion of S Protein with Host Cell Membrane
There are two mechanisms by which membrane fusion occurs: syncytia formation and
endocytosis. Research indicates that the pathway by which SARS-CoV-2 can enter a host cell
depends upon the presence of certain proteases, although there is some speculation that the
type of receptor determines which fusion mechanism is used11. However, endocytosis is
observed in most CoV-2 infections in human cells6,11. Shulla et al.13 propose that palmitic acid
tails on the S protein are responsible for meditating endocytic entry into host cells. By
comparing the fusion ability of wild-type S proteins to Cys→ Ala residues in the TM-E region
of the S2 subunit, the importance of this fatty acid chain in viral infection was highlighted.
Preliminary research into the thermodynamics of SARS-CoV-2 fusion activation reveals
heightened luciferase activity at physiological temperatures compared to SARS-CoV11. As
luciferases embody a broad class of oxidative enzymes, more attention should be focused on
determining the specific metabolic pathways that are affected by CoV-2 infection. Bosch et
al. also studied the function of the fusion subunit in high thermal conditions10. HR1 and HR2
were found to be stable at temperature up to 70C, high above temperatures that the human
body can withstand. This demonstrates the persistence of the virus activity despite drastic
changes in environment.
Conclusions
Preventing ACE2 dimerization may be associated with decreased binding affinity. The Kd
of SARS-CoV-2 has been determined to be approximately 15 nM8, so an effective receptorrecognition targeting treatment should have a lower dissociation constant. Further
investigation into the gene sequence of SARS-CoV-2 may also provide better insight into its
more efficient binding to ACE2, compared to other -coronaviruses. Additionally, an
exploration of the prevalence of viral infection in cases where ACE2 concentration is low or
nonexistent will prove useful in understanding the specific role that protease receptors play
in binding and fusion. Lastly, an in-depth study of the interactions between the
transmembrane proteins should be conducted to fully grasp the mechanics of SARS-CoV-2
fusion.
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There is a substantial amount of research to suggest that SARS-CoV-2 uses the same
mode of entry into host cells through the same receptor as the virus responsible for the SARS
outbreak in 2003-2004. Although the mechanism of action of the SARS-CoV-2 virus has been
the focus of many studies as of late, further exploration into possibilities for blocking the
binding of the virus to human ACE2 is necessary. Specifically, the non-covalent interactions
between the gene sequence of ACE2 and that of SARS-CoV-2 requires better understanding
in order to design effective treatments and vaccines.
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